AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

Recruiting now

Conditions studied: Lymphoma, Non-Hodgkin, Care Coordination

In brief

This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.

Key facts

Study ID

NCT07546188

Run by

Grand Hôpital de Charleroi

People needed

210

Starts

2026-02-15

Expected to finish

2029-02-15

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients aged 18 and over who are treated in the Haematology Department at the Grand Hôpital de Charleroi from November 2025 onwards
• Treated for a lymphoma, Non Hodgkin
• Capable of giving informed consent

You may not qualify if…

• All other patients who did not meet the eligibility criteria

Where it is running

• Grand Hôpital de Charleroi — Charleroi, Hainaut, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.